LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
2.689
-0.061 (-2.22%)
Jan 29, 2025, 4:00 PM EST - Market closed
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $51.31 million as of January 29, 2025. Its market cap has increased by 3.05% in one year.
Market Cap
51.31M
Enterprise Value
75.97M
1-Year Change
3.05%
Ranking
Category
Stock Price
2.69
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from $227.76M to $51.31M, a decrease of -77.47%. That is a compound annual growth rate of -34.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2025 | 53.62M | -18.79% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 727.70B |
| UnitedHealth Group | 500.19B |
| Novo Nordisk | 389.08B |
| Johnson & Johnson | 368.10B |
| AbbVie | 312.61B |
| Merck & Co. | 247.75B |
| Abbott Laboratories | 224.49B |
| Thermo Fisher Scientific | 223.24B |